MCC Update 10-08-13
Update is an official newsletter of the Masonic Cancer Center for faculty, members, staff, colleagues, and friends. All submissions for the next issue must be sent to Sandi Sherman, firstname.lastname@example.org, by noon on Friday for publication the following Tuesday.
October 8, 2013
Note new location!
Tuesday, October 8, 2013, 12-1 p.m., 1-125 Cancer and Cardiovascular Research Building (Seminar will be videocast in 450 MCRB)
Novel mass spectrometric approaches to biomonitor exposures to environmental and dietary carcinogens
Robert Turesky, Ph.D., Professor, Department of Medicinal Chemistry, Carcinogenesis and Chemoprevention Program Member, Masonic Cancer Center
A peek at next week’s seminar
Tuesday, October 15, 2013, 12-1 p.m., 1-125 Cancer and Cardiovascular Research Building (Seminar will be videocast in 450 MCRB)
Regulating the timing of genome replication
Nicholas R. Rhind, Ph.D., Associate Professor of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School
Host: Anja Bielinsky, Ph.D.
Visit the calendar for a schedule of seminars.
Congratulations to Carol Lange, Ph.D., Cell Signaling Program leader and director of the Cancer Biology Training Grant, on being named The Clinical and Translational Science Institute 2013 Mentor of the Year. The honor also included a $1,500 award. Read more.
Kudos to Bin Ma, Ph.D., a postdoctoral associate in the laboratories of Irina Stepanov, Ph.D., and Stephen Hecht, Ph.D., on receiving the Best Oral Presentation Award at the Division of Chemical Toxicology Young Investigator Session during the American Chemical Society annual meeting in Indianapolis in September. The title of his presentation was “Analysis of a malondialdehyde-deoxyguanosine adduct in human leukocyte DNA by LC-nanoelectrospray-high resolution MS/MS."
AHC holds public forums in search for new medical school dean and vice president for health sciences
Each candidate will participate in a public forum presenting their 10-year vision for the academic health sciences if chosen.
Candidate Presentation, Q&A, and Reception
"A Vision for the Academic Health Sciences in 2023"
4:30 - 6:30 p.m., Tuesday, October 15, 2-620 Moos Tower (note time)
4:00 - 6:00 p.m., Thursday, October 17, 1-450 Moos Tower
In order to provide the candidates with adequate time to inform their colleagues of their participation in this search, candidate names and vitae will be posted the day before their campus visit on the Dean & VP search web site at: http://ahc.umn.edu/vice-president-search.
Cancer Prevention and Control Seminar
Monday, October 14, 2013, 12:15-1:15 p.m., 2-580 Moos Tower
Clinical benefits of contralateral prophylactic mastectomy for women with unilateral early-stage breast cancer
Pam Portschy, M.D., Medical Resident, Department of Surgery
Trade-offs between efficacy and cardiac toxicity of adjuvant chemotherapy in early-stage breast cancer patients. Do competing risks matter?
Fernando Alarid, MSc., Research Specialist, Division of Health Policy & Management School of Public Health, University of Minnesota
Visit the calendar for a schedule of meetings.
October 8, 2013: Specialized Centers of Research on Sex Differences (SCOR) Seminar
10 a.m., 450 MCRB
Individual differences in response to nicotine and vulnerability to nicotine addiction
Neal Benowitz, M.D., Professor, Medicine and Bioengineering & Therapeutic Sciences, Chief, Division of Clinical Pharmacology, University of California San Francisco
Light refreshments will be provided. Questions, call 612-624-0896.
October 9, 2013: Cancer Biology Research Club
12-1 p.m., 6-101 NHH
Regulation of Noxa phosphorylation and its effects on primary and leukemic T cell survival
Jenna Benson, Ph.D., Cancer Biology Training Grant postdoctoral fellow, Kelekar lab
Visit the calendar for a schedule of meetings
October 9, 2013: The Minnesota Chemoprevention Consortium
12-3 p.m., Hormel Foods Corporation, 2 Hormel Place, Austin, Minn.
If you have a proposal or data that you would like to present/discuss, please contact Steve Hecht at email@example.com.
Lunch will be provided. RSVP to firstname.lastname@example.org if you plan to attend and indicate if you would like a vegetarian lunch.
October 16, 2013: 4th Annual Masonic Cancer Center Research Symposium
10:30 a.m. to 4:30 p.m., Great Hall, Coffman Memorial Union
The Masonic Cancer Center Science Council announces its Fourth Annual Research Symposium October 16, 2013 in the Great Hall of Coffman Memorial Union from 10:30 a.m. to 3:30 p.m. The symposium will include a presentation by Douglas Yee, M.D., director of the Masonic Cancer Center, and two poster session periods.
Carl June, M.D.,
B.J. Kennedy Lecturer in Medical Oncology
Richard W. Vague Professor in Immunotherapy
Smilow Center for Translational Research
Perelman School of Medicine
University of Pennsylvania
"Engineering CARs for cancer: lessons from Detroit"
For more information visit the website.
October 16, 2013: 8th Annual Children’s Cancer Research Fund Norma Ramsay Distinguished Visiting Professor Lectureship
12:15-1:15 p.m., Riverside Campus Brennen Center
Immunotherapy with antigen-specific T-cells
Dr. Helen Heslop, , Director of the Adult Bone Marrow and Stem Cell Transplant Program, Baylor College of Medicine
October 16, 2013: CTSI-Ed Seminar Series: Building Strong Mentoring Teams
12-1 p.m., 717 Delaware St. SE, Room 105
During this seminar, junior faculty will learn how to build strong mentoring teams from Jas Ahluwalia, MD, MPH. This will include a short presentation, interactive discussion and significant opportunity for Q&A. Lunch will be provided. This seminar is part of a new, bi-monthly series to help junior faculty develop strong applications for CTSI-Ed career development programs. Reserve your spot today by emailing email@example.com. Please RSVP by Oct. 15.
October 18, 2013: Center for Bioethics Seminar Series
12:15-1:30 p.m., 2-110 Weaver Densford Hall
Re-engineering Ethics: The need for ethical innovation at the convergence of engineering and the life science
Leili Fatehi, J.D., Research Fellow, Hubert H. Humphrey School of Public Affairs, Adjunct Professor, University of Minnesota Law School
October 28, 2013: Department of Radiology Grand Rounds
5 p.m., Center for Magnetic Resonance Imaging, 2nd floor conference room
Innovation in Breast MRI
Don Plewes, M.D., University of Toronto
New clinical developments in Breast MRI-where will we be in 5 years?
Steve Harms, M.D., Mana Medical Associates
November 6, 2013: Mouse Necropsy Workshop
9-11:30 a.m., Room 495, Animal Science/Veterinary Medicine
This workshop will be led by CPSR board certified veterinary pathologists, Drs. Johnson, Kovi and O’Sullivan. It is designed for individuals who are doing in vivo studies in mice with endpoints necessitating necropsy and collection of tissues, and is appropriate for principal investigators, postdocs, graduate students and technicians. Participants will learn how to necropsy mice and identify and collect tissues of interest. Issues related to optimum handling and fixation of tissues will be emphasized. The registration fee is $100. Places are limited and reserved on a first come-first served basis. To reserve a place please email firstname.lastname@example.org.
Contact Josh Parker at 612 625 9770, email@example.com with questions.
November 20, 2013: The Power of Partnerships: Poster Session & Awards Dinner
4-7 p.m., Amherst H. Wilder Foundation, 451 Lexington Pkwy N, St. Paul, Minn. Poster session at 4:00; networking and dinner at 5:00; program at 5:30
The Program in Health Disparities Research (PHDR), Clinical and Translational Science Institute (CTSI), and Center for Health Equity (CHE) will hold their 2013 Poster Session and Awards Banquet where research presentations from the PHDR Pilot Grants in Health Disparities Research program, CTSI Collaborative Pilot Grant awardees, and research poster presentations from CHE/CTSI Scholars will be given. This poster session will also feature pilot grant awardees and the work of local community organizations dedicated to reducing health disparities.
This event is free of charge. Please RVSP here by November 15, 2013.
Visit the Education and Training Opportunities web page for more conference and special lecture listings.
May 17, 2014: Save the Date: Cancer Survivorship Series
Click here to be added to the Cancer Survivor Program mailing list to receive registration information for this conference when it is available closer to the date.
Visit the Community Events and Outreach page for more information.
Research Answers to NCI’s Provocative Questions
National Cancer Institute
Letters of Intent Due: December 16, 2013
Full Applications Due: January 15, 2014
Funding: R01s may not exceed 4 years, R21s 2 years; annual budget limits are standard.
The groups of PQs (and their respective FOAs) are:
- Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention and risk;
- Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of tumor development or recurrence;
- Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection, diagnosis, and prognosis;
- Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy; and
- Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical effectiveness.
Kimmel Scholar Award
Sidney Kimmel Foundation for Cancer Research
Deadline: December 4, 2013
Funding: $100,000/year for 2 years
Center for Evaluation and Coordination of Training and Research (CECTR) in Tobacco Regulatory Science (U54)
National Cancer Institute
Deadline: December 10, 2013
Funding: $2,000,000 total costs/year for up to 5 years
2014 Sarcoma Research Grant (pdf)
Sponsor: Karen Wyckoff Rein in Sarcoma Foundation
Deadline: November 25, 2013
Funding: $50,000 for one year.
American Cancer Society Institutional Research Grant
Deadline: November 1, 2013
This grant is for assistant professors who have no independent national funding and are engaged in cancer-related research. Cancer-related research includes cancer etiology, mechanisms of carcinogenesis and chemoprevention, molecular mechanisms of cancer progression and metastasis, development of novel cancer therapeutic or chemoprevention models and translational research, cancer immunology and immunotherapy.
This is a one-year seed grant. Funding is available up to $30,000. Applications may be obtained by emailing a request to firstname.lastname@example.org . For information, please call Aaron Schilz, 612-624-0650.
TTR Core Usage Funding Program
Sponsor: Office of Discovery and Translation - CTSI
Application Deadline (ongoing): 5 p.m. on the 10th day of any month
Funding: up to $10,000 to use a TTR-designated Core Resource for up to one year
The Core Usage Funding Program is designed to support clinical or translational projects. Basic research projects are ineligible. The supported studies may be either pilot projects, intended to generate preliminary data for larger studies, or projects nearing the final stages of completion but now require additional data the Core Resources can generate. It is expected that a Core Usage grant will be used to generate data to support an external grant submission or patent application.
Visit the Funding Opportunities Web page to see listings previously published in Update. A list of organizations that provide funding for cancer research is also provided there.